STELLA
LIVE

Serial Number

90499224

Owner

Curio Digital Therapeutics Inc

First Use Date

Jul 7, 2020

Filing Date

Jan 30, 2021

Add to watchlist:

No watchlists yet
View on USPTO

STELLA Trademark

Serial Number: 90499224

STELLA is a trademark filed by Curio Digital Therapeutics Inc on January 30, 2021. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Curio Digital Therapeutics Inc

100 Overlook Drive Floor 2 Princeton NJ
Princeton, NJ 08540

Entity Type: 03

Trademark Details

Filing Date

January 30, 2021

Registration Date

Not Registered

First Use Anywhere

July 7, 2020

First Use in Commerce

July 7, 2020

Goods & Services

Computer programming in the medical field; Consulting services in the field of providing online, non-downloadable software and applications; Medical research; Medical research services; Medical research services in the field of cancer; Medical and scientific research in the field of medical imaging; Medical and scientific research in the field of management and detection, improvement and prevention of postpartum depression and other behavioral health problems in various life stages of women; Medical and scientific research in the field of behavioral health problems in various life stages of women; Medical and scientific research information in the field of management and detection, improvement and prevention of postpartum depression and other behavioral health problems in various life stages of women; Medical and scientific research information in the field of behavioral health problems in various life stages of women; Research and development in the field of prescription digital therapeutics targeting serious medical conditions; Research and development in the field of prescription drug consulting software; Research and development in the field of optimizing the cost-effectiveness of drug prescription plans for others including the use of generic, formulary, and non-formulary drug alternatives; Research and development of computer software; Research and development of new products; Research and development of technology in the field of prescription digital therapeutics targeting serious medical conditions; Research and development of technology in the field of identifying drugs as recommended replacements; Research and development of technology in the field of prescription of therapeutic exercise programs; Research in the field of Prescription drug consulting software; Research in the field of optimizing the cost-effectiveness of drug prescription plans for others including the use of generic, formulary, and non-formulary drug alternatives; Compiling data for research purposes in the field of medical science and medical consultancy; Computer software consulting; Providing medical research and scientific research information in the field of oncology via the Internet; Providing a web site featuring technology that enables physicians to generate, manage and exchange medical information and documents regardless of medical organization or geographic location; Providing an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports; Providing information about medical research; Providing information about medical research via a website; Providing information about medical and scientific research; Providing information about medical and scientific research via a website; Scientific research; Scientific research consulting in the field of prescription digital therapeutics targeting serious medical conditions; Scientific research consulting in the field of optimizing the cost-effectiveness of drug prescription plans for others including the use of generic, formulary, and non-formulary drug alternatives; Technical research in the field of pharmaceutical studies; Technology research in the field of management and detection, improvement and prevention of postpartum depression and other behavioral health problems in various life stages of women; Technology research in the field of behavioral health problems in various life stages of women

Filing History

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 8, 2026 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 9, 2025 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Dec 8, 2025 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jun 3, 2025 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 14, 2025 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 2, 2024 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 8, 2024 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 8, 2023 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 21, 2023 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 17, 2022 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 11, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 11, 2022 GNSL
SUSPENSION LETTER WRITTEN
Feb 11, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 10, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 10, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 10, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 30, 2021 GNRN
NON-FINAL ACTION E-MAILED
Aug 30, 2021 GNRT
NON-FINAL ACTION WRITTEN
Aug 30, 2021 CNRT
ASSIGNED TO EXAMINER
Aug 19, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 3, 2021 NWOS
NEW APPLICATION ENTERED
Feb 3, 2021 NWAP